# Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD

> **NCT07187843** · — · RECRUITING · sponsor: **Azienda USL Reggio Emilia - IRCCS** · enrollment: 150 (estimated)

## Conditions studied

- Parkinson Disease
- Parkinsonian Disorders
- Brain Disease
- Basal Ganglia Diseases
- Synucleinopathies

## Interventions

- **OTHER:** Clinical assessments
- **OTHER:** Phenotypic classification

## Key facts

- **NCT ID:** NCT07187843
- **Lead sponsor:** Azienda USL Reggio Emilia - IRCCS
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-04
- **Primary completion:** 2025-10-30
- **Final completion:** 2031-05
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07187843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07187843, "Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07187843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*